Jucara and acai fruit-based dietary supplements
AssigneeK2A LLC
InventorsKenneth A. Murdock, Alexander G. Schauss
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to stable, palatable, freeze-dried, fruit-based dietary supplements. In one embodiment, the disclosures relates to compositions of Açai fruit and Jucara fruit with high antioxidant capability and cyclooxygenase-inhibitory activity, and their uses. The disclosure further provides for methods of making stable, palatable, freeze-dried, fruit-based dietary supplements from Açai fruit and Jucara fruit.
Claims7
A method of inhibiting cyclooxygenase enzyme activity in a mammal, the method comprising administering to the mammal an effective amount of a composition comprising the Jucara-based dietary supplement composition comprises:
- (a) a total anthocyanin concentration greater than about 1 milligram per gram total weight;
- (b) an ORACFL value greater than about 350 micromole TE per gram total weight;
- and
- (c) a residual water content less than about 3 weight percent of the total weight, wherein the composition quenches free radicals and reduces the damage induced by pathological free radicals;
- or an effective amount of the Jucara-based dietary supplement composition comprising:
- (a) a cyclooxygenase inhibition value greater than about 15 Aspirin® mg equivalent per gram total weight;
- and
- (b) a residual water content less than about 3 weight percent of the total weight.
A method of preventing or treating a disease or an injury associated with increased cyclooxygenase enzyme activity in a mammal, the method comprising administering to the mammal an effective amount of a composition comprising the Jucara-based dietary supplement wherein the composition comprises:
- (a) a total anthocyanin concentration greater than about 1 milligram per gram total weight;
- (b) an ORACFL value greater than about 350 micromole TE per gram total weight;
- and
- (c) a residual water content less than about 3 weight percent of the total weight, wherein the composition quenches free radicals and reduces the damage induced by pathological free radicals;
- or an effective amount of the Jucara-based dietary supplement composition comprising:
- (a) a cyclooxygenase inhibition value greater than about 15 Aspirin® mg equivalent per gram total weight;
- and
- (b) a residual water content less than about 3 weight percent of the total weight.
Dependencies are inferred from the claim text.